<p>Hood River Capital Management LLC 在最近向美國證券交易委員會（SEC）提交的文件中表示，在第二季度將其在 Guardant Health, Inc.（NASDAQ:GH - 免費報告）中的持股增加了 4.1%。該公司在本季度額外收購了 9,637 股後，持有該公司 245,701 股股票。截至其最近的 SEC 文件，Hood River Capital Management LLC 持有的 Guardant Health 約佔 0.20%，價值 12,786,000 美元。</p>
<p>獲取 <strong>Guardant Health</strong> 警報：</p>
<ul>
<li>4 只醫療保健股票大幅上漲——還有更多上漲空間</li>
</ul>
<p>其他一些對沖基金最近也調整了對 GH 的持股。IFP Advisors Inc 在第二季度將其在 Guardant Health 的股份增加了 120.1%。IFP Advisors Inc 現在持有 612 股該公司的股票，價值 33,000 美元，此前在上個季度額外購買了 334 股。Signaturefd LLC 在第二季度將其在 Guardant Health 的持股增加了 50.5%。Signaturefd LLC 現在持有 635 股該公司的股票，價值 33,000 美元，此前在上個季度額外購買了 213 股。Allworth Financial LP 在第二季度將其在 Guardant Health 的持股增加了 358.4%。Allworth Financial LP 現在持有 706 股該公司的股票，價值 37,000 美元，此前在上個季度額外購買了 552 股。FNY Investment Advisers LLC 在第二季度收購了 Guardant Health 的新股份，價值約 62,000 美元。最後，SVB Wealth LLC 在第一季度購買了 Guardant Health 的新股份，價值約 54,000 美元。機構投資者和對沖基金持有該公司 92.60% 的股票。</p>
<h2>Guardant Health 股票上漲 2.1%</h2>
<p>NASDAQ GH 的股票在週二以 104.17 美元開盤。該公司的市值為 131.3 億美元，市盈率為 -32.45，貝塔值為 1.58。Guardant Health, Inc. 的 12 個月最低價為 29.91 美元，最高價為 112.43 美元。該公司的 50 日簡單移動平均線為 85.51 美元，200 日簡單移動平均線為 63.90 美元。</p>
<ul>
<li>解讀顛覆：深入瞭解 Cathie Wood 的最新投資</li>
</ul>
<p>Guardant Health（NASDAQ:GH - 獲取免費報告）最近於 10 月 29 日星期三公佈了季度財報。該公司報告每股收益為（0.39 美元），超出市場共識預期的（0.48 美元）0.09 美元。Guardant Health 的季度收入同比增長 38.5%。去年同期，該公司每股收益為（0.88 美元）。平均而言，股票分析師預測 Guardant Health, Inc. 在本年度將發佈 -2.9 的每股收益。</p>
<h2>Guardant Health 的內部買賣</h2>
<p>在其他消息中，首席財務官 Michael Brian Bell 於 12 月 5 日星期五出售了 80,362 股該公司的股票。該股票以平均價格 103.14 美元出售，總交易額為 8,288,536.68 美元。交易完成後，首席財務官直接持有該公司 28,052 股股票，價值 2,893,283.28 美元。這代表其持股減少了 74.13%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，內部人士 Chris Freeman 於 12 月 5 日星期五出售了 31,452 股該股票。該股票以平均價格 103.07 美元出售，總價值為 3,241,757.64 美元。交易完成後，內部人士在公司中持有 25,987 股，價值約 2,678,480.09 美元。這代表其持股減少了 54.76%。該出售的披露信息可在 SEC 文件中找到。內部人士在上個季度出售了價值 21,597,632 美元的 208,653 股公司股票。公司內部人士持有該公司 6.10% 的股票。</p>
<h2>分析師評級變動</h2>
<ul>
<li>3 只快速增長的股票分析師預計價格翻倍</li>
</ul>
<p>幾家券商最近對 GH 發表了評論。TD Cowen 將 Guardant Health 的目標價格從 63.00 美元上調至 72.00 美元，並在 9 月 25 日的報告中給予該公司 “買入” 評級。Leerink Partners 將 Guardant Health 的目標價格從 70.00 美元上調至 75.00 美元，並在 9 月 25 日的研究報告中給予該公司 “跑贏大盤” 評級。Canaccord Genuity Group 在 10 月 30 日的研究報告中設定了 Guardant Health 的目標價格為 100.00 美元。花旗集團在 10 月 30 日的報告中將 Guardant Health 的目標價格從 65.00 美元上調至 100.00 美元，並給予該公司 “買入” 評級。最後，Guggenheim 在 9 月 25 日的報告中將 Guardant Health 的目標價格從 56.00 美元上調至 67.00 美元，並給予該股票 “買入” 評級。23 位研究分析師對該股票給予 “買入” 評級，1 位分析師給予該公司 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價格為 80.86 美元。</p>
<p><strong>獲取我們關於 Guardant Health 的最新報告</strong></p>
<h2>Guardant Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Guardant Health, Inc. 是一家精準腫瘤學公司，在美國和國際上提供血液和組織檢測、數據集和分析。該公司提供 Guardant360；Guardant360 LDT；Guardant360 CDx 測試；Guardant360 反應測試；Guardant360 TissueNext 測試；GuardantINFINITY 測試；GuardantConnect，一種為臨牀和生物製藥客户設計的集成軟件解決方案，旨在將接受檢測的患者與具有潛在相關臨牀研究的可操作性改變相連接；GuardantOMNI 測試用於晚期癌症；以及 GuardantINFORM，一種用於各種生物標誌物驅動癌症的腫瘤演變和治療耐藥性的計算機研究平台。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，而非 Guardant Health</li>
<li>消費品股票解析</li>
<li>根據 MarketBeat 的數據，評級最高的五隻分紅股票</li>
<li>投資汽車股票</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑對消費者健康的啓示</li>
<li>CD 計算器：定期存款計算器</li>
<li>2026 年最有可能拆分的三隻股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Guardant Health 嗎？</h2>
<p>在你考慮 Guardant Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街評級最高和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Guardant Health 並不在名單上。</p>
<p>雖然 Guardant Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Hood River Capital Management LLC 在第二季度增持了 Guardant Health, Inc. 的股份，增幅為 4.1%，目前持有 245,701 股，價值 1279 萬美元。分析師們已上調了 Guardant Health 的目標價格，多家券商給予了 “買入” 評級。內部人士最近出售了大量股份，機構投資者持有該股票的 92.60%。Guardant Health 的股票開盤價為 104.17 美元，市值為 131.3 億美元</p>

<p>Hood River Capital Management LLC raised its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 245,701 shares of the company's stock after acquiring an additional 9,637 shares during the quarter. Hood River Capital Management LLC owned approximately 0.20% of Guardant Health worth $12,786,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Hood River Capital Management LLC 在最近向美國證券交易委員會（SEC）提交的文件中表示，在第二季度將其在 Guardant Health, Inc.（NASDAQ:GH - 免費報告）中的持股增加了 4.1%。該公司在本季度額外收購了 9,637 股後，持有該公司 245,701 股股票。截至其最近的 SEC 文件，Hood River Capital Management LLC 持有的 Guardant Health 約佔 0.20%，價值 12,786,000 美元。</p>
</div><p>Get <strong>Guardant Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Guardant Health</strong> 警報：</p>
</div><ul>
<li>4 Healthcare Stocks With Massive Gains—and More to Come</li>
</ul>
<div class="lb-trans"><ul>
<li>4 只醫療保健股票大幅上漲——還有更多上漲空間</li>
</ul>
</div><p>A number of other hedge funds also recently modified their holdings of GH. IFP Advisors Inc grew its stake in shares of Guardant Health by 120.1% in the second quarter. IFP Advisors Inc now owns 612 shares of the company's stock worth $33,000 after purchasing an additional 334 shares during the last quarter. Signaturefd LLC grew its position in shares of Guardant Health by 50.5% in the 2nd quarter. Signaturefd LLC now owns 635 shares of the company's stock valued at $33,000 after buying an additional 213 shares during the last quarter. Allworth Financial LP grew its position in shares of Guardant Health by 358.4% in the 2nd quarter. Allworth Financial LP now owns 706 shares of the company's stock valued at $37,000 after buying an additional 552 shares during the last quarter. FNY Investment Advisers LLC acquired a new stake in shares of Guardant Health in the second quarter valued at about $62,000. Finally, SVB Wealth LLC bought a new position in shares of Guardant Health during the first quarter worth about $54,000. Institutional investors and hedge funds own 92.60% of the company's stock.</p>
<div class="lb-trans"><p>其他一些對沖基金最近也調整了對 GH 的持股。IFP Advisors Inc 在第二季度將其在 Guardant Health 的股份增加了 120.1%。IFP Advisors Inc 現在持有 612 股該公司的股票，價值 33,000 美元，此前在上個季度額外購買了 334 股。Signaturefd LLC 在第二季度將其在 Guardant Health 的持股增加了 50.5%。Signaturefd LLC 現在持有 635 股該公司的股票，價值 33,000 美元，此前在上個季度額外購買了 213 股。Allworth Financial LP 在第二季度將其在 Guardant Health 的持股增加了 358.4%。Allworth Financial LP 現在持有 706 股該公司的股票，價值 37,000 美元，此前在上個季度額外購買了 552 股。FNY Investment Advisers LLC 在第二季度收購了 Guardant Health 的新股份，價值約 62,000 美元。最後，SVB Wealth LLC 在第一季度購買了 Guardant Health 的新股份，價值約 54,000 美元。機構投資者和對沖基金持有該公司 92.60% 的股票。</p>
</div><h2>Guardant Health Stock Up 2.1%</h2>
<div class="lb-trans"><h2>Guardant Health 股票上漲 2.1%</h2>
</div><p>Shares of NASDAQ GH opened at $104.17 on Tuesday. The firm has a market cap of $13.13 billion, a PE ratio of -32.45 and a beta of 1.58. Guardant Health, Inc. has a 12-month low of $29.91 and a 12-month high of $112.43. The company's fifty day simple moving average is $85.51 and its 200 day simple moving average is $63.90.</p>
<div class="lb-trans"><p>NASDAQ GH 的股票在週二以 104.17 美元開盤。該公司的市值為 131.3 億美元，市盈率為 -32.45，貝塔值為 1.58。Guardant Health, Inc. 的 12 個月最低價為 29.91 美元，最高價為 112.43 美元。該公司的 50 日簡單移動平均線為 85.51 美元，200 日簡單移動平均線為 63.90 美元。</p>
</div><ul>
<li>Deciphering Disruption: Inside Cathie Wood's Latest Plays</li>
</ul>
<div class="lb-trans"><ul>
<li>解讀顛覆：深入瞭解 Cathie Wood 的最新投資</li>
</ul>
</div><p>Guardant Health (NASDAQ:GH - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.48) by $0.09. Guardant Health's quarterly revenue was up 38.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.88) EPS. On average, equities analysts predict that Guardant Health, Inc. will post -2.9 earnings per share for the current year.</p>
<div class="lb-trans"><p>Guardant Health（NASDAQ:GH - 獲取免費報告）最近於 10 月 29 日星期三公佈了季度財報。該公司報告每股收益為（0.39 美元），超出市場共識預期的（0.48 美元）0.09 美元。Guardant Health 的季度收入同比增長 38.5%。去年同期，該公司每股收益為（0.88 美元）。平均而言，股票分析師預測 Guardant Health, Inc. 在本年度將發佈 -2.9 的每股收益。</p>
</div><h2>Insider Buying and Selling at Guardant Health</h2>
<div class="lb-trans"><h2>Guardant Health 的內部買賣</h2>
</div><p>In other news, CFO Michael Brian Bell sold 80,362 shares of the company's stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average price of $103.14, for a total transaction of $8,288,536.68. Following the transaction, the chief financial officer directly owned 28,052 shares of the company's stock, valued at $2,893,283.28. This represents a 74.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, insider Chris Freeman sold 31,452 shares of the stock in a transaction on Friday, December 5th. The stock was sold at an average price of $103.07, for a total value of $3,241,757.64. Following the completion of the transaction, the insider owned 25,987 shares in the company, valued at approximately $2,678,480.09. This represents a 54.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 208,653 shares of company stock worth $21,597,632 in the last quarter. Company insiders own 6.10% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，首席財務官 Michael Brian Bell 於 12 月 5 日星期五出售了 80,362 股該公司的股票。該股票以平均價格 103.14 美元出售，總交易額為 8,288,536.68 美元。交易完成後，首席財務官直接持有該公司 28,052 股股票，價值 2,893,283.28 美元。這代表其持股減少了 74.13%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，內部人士 Chris Freeman 於 12 月 5 日星期五出售了 31,452 股該股票。該股票以平均價格 103.07 美元出售，總價值為 3,241,757.64 美元。交易完成後，內部人士在公司中持有 25,987 股，價值約 2,678,480.09 美元。這代表其持股減少了 54.76%。該出售的披露信息可在 SEC 文件中找到。內部人士在上個季度出售了價值 21,597,632 美元的 208,653 股公司股票。公司內部人士持有該公司 6.10% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>3 Fast-Growing Stocks Analysts See Doubling in Price</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只快速增長的股票分析師預計價格翻倍</li>
</ul>
</div><p>Several brokerages recently commented on GH. TD Cowen upped their target price on Guardant Health from $63.00 to $72.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, September 25th. Leerink Partners upped their price objective on shares of Guardant Health from $70.00 to $75.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, September 25th. Canaccord Genuity Group set a $100.00 price objective on shares of Guardant Health in a research report on Thursday, October 30th. Citigroup boosted their target price on shares of Guardant Health from $65.00 to $100.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 30th. Finally, Guggenheim increased their price target on Guardant Health from $56.00 to $67.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday, September 25th. Twenty-three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $80.86.</p>
<div class="lb-trans"><p>幾家券商最近對 GH 發表了評論。TD Cowen 將 Guardant Health 的目標價格從 63.00 美元上調至 72.00 美元，並在 9 月 25 日的報告中給予該公司 “買入” 評級。Leerink Partners 將 Guardant Health 的目標價格從 70.00 美元上調至 75.00 美元，並在 9 月 25 日的研究報告中給予該公司 “跑贏大盤” 評級。Canaccord Genuity Group 在 10 月 30 日的研究報告中設定了 Guardant Health 的目標價格為 100.00 美元。花旗集團在 10 月 30 日的報告中將 Guardant Health 的目標價格從 65.00 美元上調至 100.00 美元，並給予該公司 “買入” 評級。最後，Guggenheim 在 9 月 25 日的報告中將 Guardant Health 的目標價格從 56.00 美元上調至 67.00 美元，並給予該股票 “買入” 評級。23 位研究分析師對該股票給予 “買入” 評級，1 位分析師給予該公司 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價格為 80.86 美元。</p>
</div><p><strong>Get Our Latest Report on Guardant Health</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Guardant Health 的最新報告</strong></p>
</div><h2>Guardant Health Company Profile</h2>
<div class="lb-trans"><h2>Guardant Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.</p>
<div class="lb-trans"><p>Guardant Health, Inc. 是一家精準腫瘤學公司，在美國和國際上提供血液和組織檢測、數據集和分析。該公司提供 Guardant360；Guardant360 LDT；Guardant360 CDx 測試；Guardant360 反應測試；Guardant360 TissueNext 測試；GuardantINFINITY 測試；GuardantConnect，一種為臨牀和生物製藥客户設計的集成軟件解決方案，旨在將接受檢測的患者與具有潛在相關臨牀研究的可操作性改變相連接；GuardantOMNI 測試用於晚期癌症；以及 GuardantINFORM，一種用於各種生物標誌物驅動癌症的腫瘤演變和治療耐藥性的計算機研究平台。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Guardant Health</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Top 5 Highest-Rated Dividend Stocks, According to MarketBeat</li>
<li>Investing In Automotive Stocks</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
<li>CD Calculator: Certificate of Deposit Calculator</li>
<li>3 Stocks Most Likely to Split in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非 Guardant Health</li>
<li>消費品股票解析</li>
<li>根據 MarketBeat 的數據，評級最高的五隻分紅股票</li>
<li>投資汽車股票</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑對消費者健康的啓示</li>
<li>CD 計算器：定期存款計算器</li>
<li>2026 年最有可能拆分的三隻股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Guardant Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Guardant Health 嗎？</h2>
</div><p>Before you consider Guardant Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Guardant Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardant Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街評級最高和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Guardant Health 並不在名單上。</p>
</div><p>While Guardant Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Guardant Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hood River Capital Management LLC 持有 Guardant Health, Inc. $GH 價值 1279 萬美元的股票